Hints and tips:
Related Special Reports
...The three-way link up is set to be unveiled on Monday at an event in Helsingør, north of Copenhagen, to mark the Novo Nordisk Foundation’s 100th anniversary....
...Several companies with large North American operations, including betting group Flutter and building materials group CRH, have decided to quit the FTSE 100 for a primary listing in the US....
...Novo Nordisk is acquiring plants that specialise in “fill-finish” operations, the final stage of manufacturing drugs, in Indiana, Brussels and Anagni, Italy....
...The top performer in the past 12 months is Novo Nordisk, which has been boosted by investor enthusiasm over its weight loss and diabetes drugs, and is up 69 per cent....
...The “Granolas”, a recently coined acronym for Europe’s 11 best performing stocks, include the global obesity drug market leader, Novo Nordisk, chip technology company ASML and the food giant Nestlé....
...He joined Goldman in 2021 and previously led Morgan Stanley’s North American industrials investment banking business. JPMorgan has hired Alexander Mayer in a senior role, according to Bloomberg....
...Novo Holdings, the controlling shareholder of Danish drugmaker Novo Nordisk, plans to invest up to $7bn annually by 2030, as dividend payments from the maker of blockbuster diabetes drug Ozempic and weight-loss...
...Demand in the US and Europe is surging for treatments such as Wegovy, the weight-loss drug from Danish company Novo Nordisk, which was shown in a trial to reduce the risk of death by 18 per cent....
...stuart.kirk@ft.com Letters in response to this column: Governance is there to make capitalism palatable / From Claire Bodanis, Founder and Director, Falcon Windsor, London NW3, UK Novo Nordisk is controlled...
...The US has its “Magnificent Seven” tech stocks, Japan has its “Seven Samurai” and Europe has the “Granolas”: GSK, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L’Oréal, LVMH, AstraZeneca, SAP and Sanofi....
...Semaglutide can carry enormous benefits to its users, as Novo Nordisk has said....
...Need to know: Business Danish drugmaker Novo Nordisk’s breakthrough weight-loss and diabetes drugs have helped it become Europe’s largest drugmaker....
...The headlines Novo Nordisk has overtaken French luxury goods group LVMH as Europe’s most valuable company. The Danish drug maker is now worth $428bn....
...Novo Nordisk has signed deals worth up to $1bn with US biotech start-ups developing treatments for obesity and other cardiometabolic diseases, as the Wegovy manufacturer seeks to stay ahead in a major new...
...Smart reads Weight-loss glut Other drugmakers could still “win” the race in the rapidly growing obesity market dominated by Novo Nordisk and Eli Lilly, the chief executive of biotech company Zealand Pharma...
...the S&P 500 has risen 40 per cent from late 2022....
...(This summer he will renew his partnership with Alison Krauss in a North American tour.) Dian was a good match for him at the Palladium....
...These are the components of the Granolas: GSK, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L’Oréal, LVMH, AstraZeneca, SAP, Sanofi. Trips off the tongue, right? Granolas....
...Look at Diageo next to the American liquor group Brown-Forman....
...Drugs from the GLP-1 group such as Novo Nordisk’s Ozempic and Wegovy suppress appetite with remarkable effectiveness....
...Novo Nordisk became Europe’s largest company by market cap this year, its centenary. What was the first product it produced? How many of the S&P 500 companies have a female CEO?...
...where it has substantial manufacturing operations....
...Chart of the day Inspired by tales of celebrities’ dramatic weight loss, a new generation of drugs such as Novo Nordisk’s Wegovy, Ozempic and the soon to be launched Mounjaro from Eli Lilly are becoming...
...Madhumita Murgia in London Novo Nordisk’s weight-loss drug Wegovy cut the risk of death by 18 per cent, a trial finds Joe Biden and Xi Jinping meet in effort to stabilise US-China relations Geert Wilders...
...But “achieving security and co-operation in a fractured world” and artificial intelligence dominated the agenda. Jobs and growth and the compulsory climate stuff were sideshows....
International Edition